These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 32275118)
1. Management of pediatric differentiated thyroid cancer: An overview for the pediatric oncologist. Prasad PK; Mahajan P; Hawkins DS; Mostoufi-Moab S; Venkatramani R Pediatr Blood Cancer; 2020 Jun; 67(6):e28141. PubMed ID: 32275118 [TBL] [Abstract][Full Text] [Related]
2. [Treatment of differentiated carcinoma of the thyroid gland]. Mimura T; Ito K Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1184-9. PubMed ID: 9379097 [No Abstract] [Full Text] [Related]
3. Radioactive iodine remnant uptake after completion thyroidectomy: not such a complete cancer operation. Oltmann SC; Schneider DF; Leverson G; Sivashanmugam T; Chen H; Sippel RS Ann Surg Oncol; 2014 Apr; 21(4):1379-83. PubMed ID: 24378987 [TBL] [Abstract][Full Text] [Related]
4. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis. Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176 [TBL] [Abstract][Full Text] [Related]
5. Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. U.S. and German Thyroid Cancer Group. Hölzer S; Reiners C; Mann K; Bamberg M; Rothmund M; Dudeck J; Stewart AK; Hundahl SA Cancer; 2000 Jul; 89(1):192-201. PubMed ID: 10897018 [TBL] [Abstract][Full Text] [Related]
6. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506 [TBL] [Abstract][Full Text] [Related]
7. Role of [ Xu Q; Liu R; Wang J; Huang Y; Li S; Zhang L; Wang F Nucl Med Biol; 2020; 88-89():34-43. PubMed ID: 32688289 [TBL] [Abstract][Full Text] [Related]
8. Well differentiated thyroid cancer. Kinder BK Curr Opin Oncol; 2003 Jan; 15(1):71-7. PubMed ID: 12490765 [TBL] [Abstract][Full Text] [Related]
10. Molecular targets of tyrosine kinase inhibitors in thyroid cancer. Fallahi P; Ferrari SM; Galdiero MR; Varricchi G; Elia G; Ragusa F; Paparo SR; Benvenga S; Antonelli A Semin Cancer Biol; 2022 Feb; 79():180-196. PubMed ID: 33249201 [TBL] [Abstract][Full Text] [Related]
11. Unusual presentations of differentiated thyroid cancer: analysis of 55 cases from North India. Bhansali A; Dutta P; Reddy KS; Masoodi SR; Radotra BD; Kumar V; Mittal BR Ann Saudi Med; 2005; 25(5):428-32. PubMed ID: 16270771 [No Abstract] [Full Text] [Related]
12. Management of invasive and advanced thyroid cancer. Favia G; Iacobone M; Zanella S; Ciarleglio FA Minerva Endocrinol; 2009 Mar; 34(1):37-55. PubMed ID: 19209127 [TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution. Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic strategy for low-risk thyroid cancer in Kanaji Thyroid Hospital. Kammori M; Fukumori T; Sugishita Y; Hoshi M; Yamada T Endocr J; 2014; 61(1):1-12. PubMed ID: 24067543 [TBL] [Abstract][Full Text] [Related]
15. [Recovery rate in differentiated thyroid cancer. Experiences of one of the Hungarian clinical centers]. Szujó S; Bajnok L; Bódis B; Nemes O; Rucz K; Mezősi E Orv Hetil; 2018 Jun; 159(22):878-884. PubMed ID: 29806478 [TBL] [Abstract][Full Text] [Related]
16. Thyroid Cancer: Risk-Stratified Management and Individualized Therapy. Raue F; Frank-Raue K Clin Cancer Res; 2016 Oct; 22(20):5012-5021. PubMed ID: 27742787 [TBL] [Abstract][Full Text] [Related]
17. Radioactive iodine (RAI) therapy for distantly metastatic differentiated thyroid cancer (DTC) in juvenile versus adult patients. Kammori M; Fukumori T; Sugishita Y; Hoshi M; Shimizu K; Yamada T Endocr J; 2015; 62(12):1067-75. PubMed ID: 26424174 [TBL] [Abstract][Full Text] [Related]
18. Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory. Lamartina L; Durante C; Lucisano G; Grani G; Bellantone R; Lombardi CP; Pontecorvi A; Arvat E; Felicetti F; Zatelli MC; Rossi R; Puxeddu E; Morelli S; Torlontano M; Crocetti U; Montesano T; Giubbini R; Orlandi F; Aimaretti G; Monzani F; Attard M; Francese C; Antonelli A; Limone P; Rossetto R; Fugazzola L; Meringolo D; Bruno R; Tumino S; Ceresini G; Centanni M; Monti S; Salvatore D; Spiazzi G; Mian C; Persani L; Barbaro D; Nicolucci A; Filetti S Thyroid; 2017 Dec; 27(12):1490-1497. PubMed ID: 29020892 [TBL] [Abstract][Full Text] [Related]
19. Impact of Patient Age and Histological Type on Radioactive Iodine Avidity of Recurrent Lesions of Differentiated Thyroid Carcinoma. Nakanishi K; Kikumori T; Miyajima N; Takano Y; Noda S; Takeuchi D; Iwano S; Kodera Y Clin Nucl Med; 2018 Jul; 43(7):482-485. PubMed ID: 29688947 [TBL] [Abstract][Full Text] [Related]